Introduction
Heroin consumption in Catalonia increased spectacularly during the 1980s. Resources dedicated to treatment of addicts were increased and the EMETYST Project was started to assess treatment and describe the natural history of heroin addiction in Catalonia (Brigos, Camṍ & Sánchez-Carbonell, 1988; Sánchez-Carbonell, Camṍ & Brigos, 1988; Sánchez-Carbonell, Brigos & Camṍ, 1989) . Since then, more than 10 years have passed and a follow-up of the same cohort would allow us, therefore, to study the natural history of heroin addiction in Catalonia. In studies on cohorts of opiate addicts in the 1970s and 1980s it may be observed that mortality lies between 1% and 3% per year (Vaillant 1966 (Vaillant , 1973 Chapple, Somekeh & Taylor, 1972; Stimson, Oppenheimer &Thorley, 1978; Maddux & Desmond, 1980 , 1986 Joe, Lehman & Simpson, 1982; Barr et al., 1984; Haastrup & Jepsen, 1984 , 1988 Cottrell Childs-Clarke & Ghodse, 1985; Edwards & Goldie, 1987; Joe & Simpson, 1987; Tunving, 1988) . The in uence of AIDS, changes in consumption pat- terns and social and cultural differences led us to think that the frequency and causes of death in the countries of Southern Europe are different from those described for heroin addicts in Anglo-Saxon countries. This phase of the EMETYST Project was designed to obtain information about the frequency and basic causes of death among heroin addicts who began treatment in Catalonia in 1985 and to compare them with those of other European countries.
Method

Subjects
Between March 1 and July 30 1985, 138 heroin addicts applied for treatment for the rst time in one of the four centres collaborating with the EMETYST Project in Catalonia (Hospital del Mar, Dispensario de la Cruz Roja and SPOTT, in the city of Barcelona, and Centro Municipal de Drogodependencias in L'Hospitalet de Llobregat). They agreed to take part in a study on treatment assessment. In this follow-up, three patients were excluded due to insuf cient information about their identity. Therefore, the nal sample was 135 heroin addicts.
Data sources and procedure
The vital status of the EMETYST cohort was examined for the 10.5-year period, from March 1 1985 to December 31 1995 in the Catalonia Mortality Registry (CMR). The CMR collects all the deaths that occur in Catalonia and the deaths of people living in Catalonia that take place in other geographical areas. To avoid possible under-noti cation due to delays with the incorporation of data to the CMR, we started consultation in May 1997. In the case of death, the date and basic cause of death was coded according to the ninth revision of the International Classi cation of Diseases (ICD-9), by the World Health Organization (WHO, 1977) .
Data analysis
A number of indicators were analysed: (a) number of total and annual events; (b) annual mortality rate (the number of people at risk was obtained by subtracting from 135, the number of deaths until December 31 of the previous year); (c) average annual mortality rate (AMR) (as the incorporation of the cohort took place between March and July 1985 and the cut-off point in December 1995, the denominator was xed as 10.5 years); and (d) standardized mortality ratios (SMR) and their 95% con dence intervals (CI) with regard to the general population of Catalonia, controlled by age and period. Survival analysis (Kaplan-Meier: log rank test) was used to assess the predictive factors. The period of survival of each person was calculated between the date of entry into this study and the date of death or date of censure if still alive. The variables used to characterize the sample were also used as survival predictors. In the comparison of qualitative variables, the chi-square test was used. Statistical signi cance was set at p , 0.05. All analyses were carried out using SPSS 8.0 for Windows.
Results
At the beginning of treatment in 1985 71% of heroin addicts were men, with an average age of 23.6 years (SD 5 3.48) and they mainly lived with their family (73%). In the last year, 70% had worked at least 1 day and 22% had been in prison at least 1 day. Their average age when they started to take heroin was 18.7 years (SD 5 3.24) and 47% had been under treatment previously (Table 1) . Table 2 shows the evolution of mortality. From the beginning of treatment in March 1985 until December 1995, 41 drug addicts died (30.4%), 31 men and 10 women. At death, the average age was 31 years; 41.5% died before they were 30. The years when more addicts died were 1992, 1993 and 1995 (eight cases per year) and the year with the highest mortality rate was 1995 (7.84%). The average annual mortality rate was 3.4%. Survival decreased, particularly after 1990, without reaching stabilization before the end of the period. As 41 deaths were observed in comparison to the 1.43 deaths expected among the general population, the SMR was 28.58 (95% CI, 14.65 -42.65). That is, a heroin addict of the cohort had a risk of dying 29 times higher than that of a person of the general population of the same age in this period.
The most frequent causes of death fell within ICD-9 III (nutritional, endocrine and immune system disorders, which include AIDS) with 21 cases (17 men and four women) and within ICD-9 XVII (poisonings, accidents and suicide, which includes overdose) with 13 cases 
Discussion
This group of heroin addicts is mainly male, in their mid-twenties, take heroin intravenously and live with their family of origin. Given that they share many characteristics with other addicts who applied for treatment in other specialized centres in Catalonia in the 1980s (Guardia, Masip & Viladrich, 1988; Melgarejo et al., 1988; Muga et al., 1990) , we may reasonably assume the survival of this cohort to be representative of that of addicts in Catalonia in general. It was a pleasant surprise to nd that 70% of these addicts were alive almost 11 years after applying for treatment, while the impression of professionals in treatment clinics was more pessimistic. Nevertheless, mortality has not reached stabilization, which suggests that heroin addicts will continue to die in the coming years, as shown by the preliminary mortality data in 1996 (two deaths) and 1997 (three deaths). When examining the annual mortality rate it may be observed that: (a) between 1985 and 1990, it lies between 1% and 3%, which would accord with the observations of cohort studies in the 1970s and 1980s; and (b) as from 1990 the annual mortality rate increased dramatically to 7.84% in 1995.
When studying the time distribution of causes of death we observe the rising importance of immune system disorders, which were of no relevance in Catalonia in the 1980s (Muga et al., 1990) . This rise has already been described (Perucci, 1991; Selwyn, 1991; Ortṍ et al. 1996) , although our cohort is the rst in a European Union country to reach 51% of deaths due to this cause.
(10 men and three women). These two groups accounted for 83% of deaths. The other seven cases ( ve men and two women) corresponded to the following chapters: tumours (three cases), cerebral, circulatory, respiratory and circulatory (one case each). Table 3 shows the biannual distribution of causes of death. The causes of death that belong to ICD-9 III increased, whereas the evolution of external causes and the other causes was irregular.
The demographic characteristics and those of Table 3 
. Biannual evolution of causes of death, grouped into three categories: (a) nutritional, endocrine and immune system, (b) external causes (poisonings, accidents and suicide) and (c) other causes
Causes of death (ICD-9) 1986-87 1988-89 1990-91 1992-93 1994-95 Immune system  0  1  5  7  8  External  3  0  2  5  3  Other causes  0  0  1  4  2 Although most members of the cohort lived in Barcelona, the period of the highest death rate among the cohort does not coincide with the period 1987 -89, when mortality in the city of Barcelona due to acute adverse drug reactions, understood as pharmacological overdose, allergic reactions and adulterant toxic reactions, was highest (Brugal et al., 1995) . This could be due to the fact that acute adverse drug reactions together with other external causes are responsible for only a third of the causes of death in our cohort.
Comparison with other European countries
When comparing data from this study with European literature (Table 4) , we observe that: (a) the average annual mortality rate in Catalonia is almost twice that among cohorts in Great Britain and similar to that in Scandinavian countries; (b) the survival rate, in comparison to the general population, is lower than that of their peers in other European countries; and (c) Catalonia has a very high rate of deaths attributable to AIDS and immune system disorders.
Predicting factors
There were no statistically signi cant predictors, which could be due to three reasons. First, it is dif cult to make predictions about survival after 10.5 years on the basis of concrete information reported at the beginning of treatment, which may undergo modi cations. Secondly, given the importance of immune system disorders in the causes of death among the cohort, it may be possible that HIV infection was such a powerful predictor of death that it swamped the rest of the predictive factors. Thirdly, a review of the literature (Oppenheimer et al. 1994; Ortṍ et al. 1996; Frischer et al. 1997; Fugelstad et al. 1997 ) reveals a wide disparity in the power attributed to the various predictive factors, the only exception being HIV injection. It is also worth considering that a wide range of predicting factors with different operational de nitions appear in the literature; in practice, sex would be the only predictor with the same operational de nition in all the studies.
Abstinence versus risk decrease
The annual mortality rate was the highest of those described in American and European literature for drug addicts, both in comparison to other addict populations and in relation to the general population, and it is different from that of other industrialized countries. How has this occurred? Although we could consider different hypotheses to explain this fact (social discrimination due to unemployment and low educational level, life-style, lack of information about sources of infection and low ful lment of prevention measures), the limitation of therapeutic use of opiate agonists may possibly be the main factor. Whereas methadone maintenance is a treatment model well established in other countries, in Spain legislation regarding its therapeutic use has been subject to frequent changes (Ministry of Health and Consumption, 1983 . The shortage of methadone maintenance programmes and the low adherence to drug-free treatment programmes, estimated at 8% and 16% after 12 months (Melgarejo et al., 1988; Sánchez-Carbonell et al., 1988; Garcṍa & Ezquiaga, 1991; Sánchez-Carbonell, 1993) , are together responsible for reducing long-term survival among this collective.
Limitations
The small size of our sample may have reduced the statistical signi cance of the predicting value of demographic characteristics and may have increased the size of the con dence interval of the SMR. In those deaths classi ed in ICD-9 III, it has not been possible to distinguish between endocrine, nutritional and immune system disorders. There is always a risk of under-noti cation of certain socially stigmatized diseases such as AIDS (Buehler et al., 1990; De la Fuente et al., 1995; Ortṍ et al., 1996) . The international comparison of causes of death through mortality registers has some known problems: when registers of different cultural areas are compared, there may be differences of criteria in the information processing, and these differences can be due to non-speci c factors such as the quality of registers (Benavides, Bolú mar & Peris, 1989; Moriyama, 1989) . Studies using similar, but not identical, criteria when recruiting the cohort have been compared: heroin addicts vs. opioid addicts vs. drug addicts vs. drug injectors.
Conclusions
In conclusion, heroin addicts in Catalonia show a high mortality rate and, in comparison to the general population, the mortality rate is higher in Catalonia than in any other European country. The main cause of death is AIDS, which points out the differences in the career of addicts due to health care conditions determined by place of residence and period. The differences and similarities between countries could justify a comparative study on mortality and its causes in the European Union. Long-term survival predictors must be interpreted with caution, with the exception of being HIV-positive or being diagnosed with AIDS. In future research, vital status could be complemented with other health indicators. In this sense, our research group is currently working with of cial registers of AIDS and tuberculosis, diseases of obligatory individual declaration in Catalonia, and with the register of drug addiction treatment, with the objective of describing the addiction career of this collective in further detail.
